once monthly glp 1 agonist Berobenatide is a new investigational ultra-long-acting GLP-1 RA designed for dosing. Data was just reviewed at the ADA annual meeting. ๐๐ผ Unlike conventional GLP-1RAs, berobenatide is a fully BIASED (it curb cravings Medication:Tirzepatide (GLP-1 + GIP) TRIPLE G 5 mg
TRIPLE G 5 mg triple GLP-1/GIP/glucagon agonist | PRO-BODY
Additionally, setting personal goals can help make GLP-1 medications more effective
curb cravings
Medication:Tirzepatide (GLP-1 + GIP)
[DOI] [PMC free article] [PubMed] [Google Scholar] 56.Rossing P, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Fonseca V, Umpierrez GE, Caramori ML, Joseph A, et al